Dr. Rudin on Immunotherapy Biomarkers in Lung Cancer – OncLive
OncLive |
Dr. Rudin on Immunotherapy Biomarkers in Lung Cancer
OncLive Charles M. Rudin, MD, PhD, chief, Thoracic Oncology Service, co-director, Druckenmiller Center for Lung Cancer Research, Sylvia Hassenfeld Chair in Lung Cancer Research, Memorial Sloan Kettering Cancer Center, discusses biomarkers for immunotherapy in … |
